The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 02, 2025
Filed:
Dec. 19, 2019
Applicants:
Vir Biotechnology, Inc., San Francisco, CA (US);
Humabs Biomed SA, Bellinzona, CH;
Inventors:
Anna Bakardjiev, San Francisco, CA (US);
Phillip S. Pang, Menlo Park, CA (US);
Davide Corti, Bellinzona, CH;
Assignees:
Vir Biotechnology, Inc., San Francisco, CA (US);
Humabs BioMed SA, Bellinzona, CH;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/08 (2006.01); A61K 31/7105 (2006.01); A61K 39/00 (2006.01); A61K 39/42 (2006.01); A61K 47/54 (2017.01); A61P 31/20 (2006.01);
U.S. Cl.
CPC ...
C07K 16/082 (2013.01); A61K 31/7105 (2013.01); A61K 39/42 (2013.01); A61K 47/549 (2017.08); A61P 31/20 (2018.01); A61K 2039/505 (2013.01); A61K 2039/545 (2013.01); C07K 2317/24 (2013.01); C07K 2317/76 (2013.01);
Abstract
The present disclosure provides methods for treating HBV infection using combination therapies, and related kits and compositions for use. The components of the combination therapies include an inhibitor of HBV gene expression or an agent that reduces HBV antigenic load, and an anti-HBV antibody.